AGO2 and inflammatory skin disease: MicroRNA-184 has also been shown to increase in response to interleukin-22 (IL-22), a proinflammatory cytokine associated with inflammatory skin disorders, thereby reducing expression of Argonaute-2 (AGO 2) protein in human keratinocytes [46].